First GM pigs for allergies. Could xenotransplants be next?

Elie Dolgin • April 12, 2021

The FDA greenlights α-Gal allergy-safe meat, but its makers have organs for transplants in their sights.

The first genetically engineered pig products could soon be coming to a dinner plate—or pharmacy—near you. Late last year, the US Food and Drug Administration (FDA) authorized a facility in northern Iowa to raise hogs that lack the gene needed to produce galactose-α-1,3-galactose (α-Gal), a sugar molecule found naturally on the surface of porcine cells.


Trademarked under the name ‘GalSafe’, the pigs could now provide a source of meat for people who develop tick bite–induced allergic reactions to the sugar, a condition known as α-Gal syndrome. Byproducts of pork production could also be harvested to make allergy-free pharmaceuticals and medical implants. The porcine tissue could help overcome deficiencies in the donor supply of skin and nerve grafts.


Continue reading at Nature Biotechnology.

‘Connectoids’ use microfluid channels to recapitulate and study neural connections.
By Elie Dolgin May 14, 2025
With organoids, assembloids and a growing bioengineering toolkit, scientists are pushing the limits of human brain models.
Picture of scientist handling mRNA, Robert F. Kennedy Jr. and vaccine protesters.
By Elie Dolgin May 9, 2025
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.